Acquisition Blogging Layoffs Pricing 
Xconomy
OCTOBER 7, 2016
PRICE FIGHTS. With some caveats, ICER recommended lower prices. —Merrimack Pharmaceuticals (NASDAQ: MACK ) announced layoffs of 22 percent of its staff and the resignation of CEO Robert Mulroy. Territorial Acquisitions” by Joaquin Martinez via Creative Commons. for their work on molecular machines.
Xconomy
JULY 1, 2016
At the gathering, Biden took verbal shots at scofflaw cancer researchers and at drug prices, while the FDA said it would take a shot at restructuring the way it evaluates oncology products. Gilead Sciences has been a target of drug-price criticism for its hepatitis C treatments, but it dialed back the price of its new one.
Expert insights. Personalized for you.
77 
Let's personalize your content